Ontology type: schema:ScholarlyArticle Open Access: True
2008-01
AUTHORSKeiko Nakayama, Yoichi Kuwabara, Masao Daimon, Satoshi Shindo, Miwa Fujita, Hiroya Narumi, Hiroshi Mizuma, Issei Komuro
ABSTRACTAntihypertensive therapy has been well established to reduce hypertension-related morbidity and mortality, but the optimal therapy for Japanese patients remains unknown. The Valsartan Amlodipine Randomized Trial (VART), a prospective randomized open-label trial, was designed to determine whether treatment with an angiotensin II type 1 receptor blocker (valsartan) or a calcium channel blocker (amlodipine) lowers cardiovascular disease events in essential hypertensives in Japan. Registration, randomization and data entry were performed over the Internet. The minimization method (to control for age, gender, blood pressure level and history) was used at random assignment to ensure that the background factors were equivalent between the groups at baseline. After the registration, patients were followed-up for cardiovascular events (primary endpoints), echocardiography, 123I-metaiodobenzylguanidine (MIBG) imaging, laboratory tests and blood pressure for 3 years. Currently, 797 patients have been enrolled and assigned to two groups: a valsartan (n=399) and an amlodipine (n=398) group. At baseline, controlled factors (age, gender, blood pressure level, and left ventricular hypertrophy) and the proportions of patients with diabetes and hyperlipidemia were equally allocated. At 12 months, both drugs evenly and significantly lowered blood pressure to the target level (valsartan: 133/79 mmHg; amlodipine: 132/79 mmHg). In conclusion, by combining the data on cardiovascular events with the results of echocardiographic, radionuclide imaging, and blood/urine studies, the VART study will provide mechanistic insights into the clinical outcomes and treatment effects of the trial. (Hypertens Res 2008; 31: 21−28) More... »
PAGES21-28
http://scigraph.springernature.com/pub.10.1291/hypres.31.21
DOIhttp://dx.doi.org/10.1291/hypres.31.21
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1010763509
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/18360014
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "3-Iodobenzylguanidine",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Amlodipine",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Angiotensin II Type 1 Receptor Blockers",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antihypertensive Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Calcium Channel Blockers",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Data Interpretation, Statistical",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Endpoint Determination",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Follow-Up Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hypertension",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Informed Consent",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Patient Selection",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Radionuclide Imaging",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Radiopharmaceuticals",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Research Design",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Risk Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Sample Size",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Tetrazoles",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Ultrasonography",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Valine",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Valsartan",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan",
"id": "http://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Nakayama",
"givenName": "Keiko",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan",
"id": "http://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Kuwabara",
"givenName": "Yoichi",
"id": "sg:person.0752532133.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752532133.65"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan",
"id": "http://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Daimon",
"givenName": "Masao",
"id": "sg:person.01312065070.00",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312065070.00"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan",
"id": "http://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Shindo",
"givenName": "Satoshi",
"id": "sg:person.01066760533.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066760533.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan",
"id": "http://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Fujita",
"givenName": "Miwa",
"id": "sg:person.01135073733.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135073733.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan",
"id": "http://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Narumi",
"givenName": "Hiroya",
"id": "sg:person.01203207133.99",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203207133.99"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan",
"id": "http://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Mizuma",
"givenName": "Hiroshi",
"id": "sg:person.01251322333.16",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251322333.16"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan",
"id": "http://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan"
],
"type": "Organization"
},
"familyName": "Komuro",
"givenName": "Issei",
"id": "sg:person.01012024207.33",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012024207.33"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1291/hypres.28.865",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050983237",
"https://doi.org/10.1291/hypres.28.865"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.2165/00003495-199447060-00005",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034980850",
"https://doi.org/10.2165/00003495-199447060-00005"
],
"type": "CreativeWork"
}
],
"datePublished": "2008-01",
"datePublishedReg": "2008-01-01",
"description": "Antihypertensive therapy has been well established to reduce hypertension-related morbidity and mortality, but the optimal therapy for Japanese patients remains unknown. The Valsartan Amlodipine Randomized Trial (VART), a prospective randomized open-label trial, was designed to determine whether treatment with an angiotensin II type 1 receptor blocker (valsartan) or a calcium channel blocker (amlodipine) lowers cardiovascular disease events in essential hypertensives in Japan. Registration, randomization and data entry were performed over the Internet. The minimization method (to control for age, gender, blood pressure level and history) was used at random assignment to ensure that the background factors were equivalent between the groups at baseline. After the registration, patients were followed-up for cardiovascular events (primary endpoints), echocardiography, 123I-metaiodobenzylguanidine (MIBG) imaging, laboratory tests and blood pressure for 3 years. Currently, 797 patients have been enrolled and assigned to two groups: a valsartan (n=399) and an amlodipine (n=398) group. At baseline, controlled factors (age, gender, blood pressure level, and left ventricular hypertrophy) and the proportions of patients with diabetes and hyperlipidemia were equally allocated. At 12 months, both drugs evenly and significantly lowered blood pressure to the target level (valsartan: 133/79 mmHg; amlodipine: 132/79 mmHg). In conclusion, by combining the data on cardiovascular events with the results of echocardiographic, radionuclide imaging, and blood/urine studies, the VART study will provide mechanistic insights into the clinical outcomes and treatment effects of the trial. (Hypertens Res 2008; 31: 21\u221228)",
"genre": "article",
"id": "sg:pub.10.1291/hypres.31.21",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1313717",
"issn": [
"0916-9636",
"1348-4214"
],
"name": "Hypertension Research",
"publisher": "Japanese Society of Hypertension",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "31"
}
],
"keywords": [
"cardiovascular events",
"blood pressure",
"randomized trials",
"angiotensin II type 1 receptor blocker",
"type 1 receptor blocker",
"hypertension-related morbidity",
"open-label trial",
"cardiovascular disease events",
"proportion of patients",
"calcium channel blockers",
"antihypertensive therapy",
"amlodipine group",
"receptor blockers",
"essential hypertensives",
"optimal therapy",
"clinical outcomes",
"Japanese patients",
"urine studies",
"channel blockers",
"disease events",
"patients",
"trials",
"treatment effects",
"blockers",
"therapy",
"background factors",
"baseline",
"random assignment",
"target level",
"laboratory tests",
"group",
"hypertensives",
"data entry",
"hyperlipidemia",
"morbidity",
"echocardiography",
"diabetes",
"valsartan",
"mortality",
"months",
"drugs",
"outcomes",
"treatment",
"factors",
"events",
"mechanistic insights",
"randomization",
"study",
"conclusion",
"imaging",
"preliminary results",
"pressure",
"years",
"proportion",
"registration",
"levels",
"entry",
"test",
"effect",
"results",
"data",
"Japan",
"method",
"radionuclides",
"insights",
"design",
"assignment",
"Internet",
"minimization method"
],
"name": "Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results",
"pagination": "21-28",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1010763509"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1291/hypres.31.21"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"18360014"
]
}
],
"sameAs": [
"https://doi.org/10.1291/hypres.31.21",
"https://app.dimensions.ai/details/publication/pub.1010763509"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:24",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_464.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1291/hypres.31.21"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1291/hypres.31.21'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1291/hypres.31.21'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1291/hypres.31.21'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1291/hypres.31.21'
This table displays all metadata directly associated to this object as RDF triples.
291 TRIPLES
22 PREDICATES
124 URIs
114 LITERALS
33 BLANK NODES